Private Capital Group, LLC Sarepta Therapeutics, Inc. Transaction History

Private Capital Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 24, 2022	SELL	$77.28 - $99.42 $4,636 - $5,965	-60 Closed	0 $0
Q3 2021 Oct 13, 2021	BUY	$65.97 - $92.48 $2,704 - $3,791	41 Added 215.79%	60 $6,000
Q2 2021 Jul 26, 2021	BUY	$69.38 - $86.75 $1,318 - $1,648	19 New	19 $2,000
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $5,510 - $9,761	-72 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$72.81 - $156.91 $5,242 - $11,297	72 New	72 $5,000
Q4 2018 Jan 28, 2019	SELL	$97.32 - $148.76 $875 - $1,338	-9 Closed	0 $0
Q3 2018 Oct 31, 2018	BUY	$115.31 - $161.51 $1,037 - $1,453	9 New	9 $1,000

529

84.1M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Capital Group, LLC with notifications on news.